505 parallel-and-distributed-computing-phd positions at University of Maryland, Baltimore
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
professional development, along with additional exciting perks that employees can take advantage of. This position participates in a retirement program (pension or optional retirement plan/ORP) that must be
-
of. This position participates in a retirement program (pension), effective on your date of hire. Exempt regular staff receive a generous PAID leave package that starts with 14 days of vacation accrued per year, 15
-
take advantage of. This position participates in a retirement program (pension or optional retirement plan/ORP) that must be selected and is effective on your date of hire. Exempt regular staff receive a
-
wellness, work/life balance, and professional development, along with additional exciting perks that employees can take advantage of. This position participates in a retirement program (pension or optional
-
-month, full-time, tenure track faculty position. Outstanding scholars with an established and highly successful research program with interests that complement and extend existing areas of excellence in
-
program (pension or optional retirement plan/ORP) that must be selected and is effective on your date of hire. Exempt regular staff receive a generous PAID leave package that includes over 4 weeks
-
- Program in Trauma Job Posting : Aug 26, 2025 Unposting Date : Sep 2, 2025, 11:59:00 PM
-
on faculty rank and years in rank. This salary range does not include all components of the Department of Anesthesiology faculty compensation program or pay from participation in Department of Anesthesiology
-
on faculty rank and years in rank. This salary range does not include all components of the departmental faculty compensation program or pay from participation in departmental variable compensation programs
-
for the Solid Tumor research program. Following an extensive training program, the Clinical Research Specialist will be assigned a portfolio of cutting-edge novel therapeutic trials and will be the primary